nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT2B7—Epirubicin—testicular cancer	0.126	0.159	CbGbCtD
Fluvastatin—UGT1A1—Etoposide—testicular cancer	0.0848	0.107	CbGbCtD
Fluvastatin—CYP2B6—Ifosfamide—testicular cancer	0.0687	0.0867	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—testicular cancer	0.0666	0.0841	CbGbCtD
Fluvastatin—CYP3A5—Ifosfamide—testicular cancer	0.0541	0.0683	CbGbCtD
Fluvastatin—CYP2C8—Ifosfamide—testicular cancer	0.052	0.0657	CbGbCtD
Fluvastatin—CYP2C19—Ifosfamide—testicular cancer	0.0436	0.0551	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—testicular cancer	0.0388	0.049	CbGbCtD
Fluvastatin—CYP2C9—Ifosfamide—testicular cancer	0.0363	0.0458	CbGbCtD
Fluvastatin—CYP2B6—Cisplatin—testicular cancer	0.0334	0.0422	CbGbCtD
Fluvastatin—CYP3A5—Etoposide—testicular cancer	0.0259	0.0326	CbGbCtD
Fluvastatin—CYP2C8—Etoposide—testicular cancer	0.0249	0.0314	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—testicular cancer	0.0224	0.0283	CbGbCtD
Fluvastatin—CYP3A4—Ifosfamide—testicular cancer	0.0211	0.0266	CbGbCtD
Fluvastatin—CYP1A2—Etoposide—testicular cancer	0.0192	0.0243	CbGbCtD
Fluvastatin—CYP2C9—Cisplatin—testicular cancer	0.0176	0.0223	CbGbCtD
Fluvastatin—CYP2D6—Vinblastine—testicular cancer	0.0176	0.0222	CbGbCtD
Fluvastatin—CYP3A4—Vinblastine—testicular cancer	0.0112	0.0141	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—testicular cancer	0.0108	0.0137	CbGbCtD
Fluvastatin—CYP3A4—Etoposide—testicular cancer	0.0101	0.0127	CbGbCtD
Fluvastatin—CYP3A4—Doxorubicin—testicular cancer	0.00688	0.00868	CbGbCtD
Fluvastatin—Infestation—Epirubicin—testicular cancer	0.000244	0.00117	CcSEcCtD
Fluvastatin—Vomiting—Dactinomycin—testicular cancer	0.000244	0.00117	CcSEcCtD
Fluvastatin—Bronchitis—Doxorubicin—testicular cancer	0.000243	0.00117	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000242	0.00116	CcSEcCtD
Fluvastatin—Rash—Dactinomycin—testicular cancer	0.000242	0.00116	CcSEcCtD
Fluvastatin—Decreased appetite—Etoposide—testicular cancer	0.000241	0.00116	CcSEcCtD
Fluvastatin—Diarrhoea—Ifosfamide—testicular cancer	0.00024	0.00116	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00024	0.00115	CcSEcCtD
Fluvastatin—Body temperature increased—Cisplatin—testicular cancer	0.000239	0.00115	CcSEcCtD
Fluvastatin—Fatigue—Etoposide—testicular cancer	0.000239	0.00115	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000239	0.00115	CcSEcCtD
Fluvastatin—Pain—Etoposide—testicular cancer	0.000237	0.00114	CcSEcCtD
Fluvastatin—Constipation—Etoposide—testicular cancer	0.000237	0.00114	CcSEcCtD
Fluvastatin—Urinary tract infection—Epirubicin—testicular cancer	0.000237	0.00114	CcSEcCtD
Fluvastatin—Conjunctivitis—Epirubicin—testicular cancer	0.000237	0.00114	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000235	0.00113	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—testicular cancer	0.000234	0.00113	CcSEcCtD
Fluvastatin—Sweating—Epirubicin—testicular cancer	0.000234	0.00112	CcSEcCtD
Fluvastatin—Dizziness—Ifosfamide—testicular cancer	0.000232	0.00112	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—testicular cancer	0.000232	0.00112	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000231	0.00111	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000231	0.00111	CcSEcCtD
Fluvastatin—Sinusitis—Epirubicin—testicular cancer	0.000229	0.0011	CcSEcCtD
Fluvastatin—Feeling abnormal—Etoposide—testicular cancer	0.000229	0.0011	CcSEcCtD
Fluvastatin—Nausea—Dactinomycin—testicular cancer	0.000228	0.0011	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Etoposide—testicular cancer	0.000227	0.00109	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—testicular cancer	0.000226	0.00109	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—testicular cancer	0.000226	0.00109	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—testicular cancer	0.000225	0.00108	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000224	0.00108	CcSEcCtD
Fluvastatin—Vomiting—Ifosfamide—testicular cancer	0.000223	0.00107	CcSEcCtD
Fluvastatin—Hypersensitivity—Cisplatin—testicular cancer	0.000223	0.00107	CcSEcCtD
Fluvastatin—Rash—Ifosfamide—testicular cancer	0.000222	0.00107	CcSEcCtD
Fluvastatin—Dermatitis—Ifosfamide—testicular cancer	0.000221	0.00106	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—testicular cancer	0.000221	0.00106	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000221	0.00106	CcSEcCtD
Fluvastatin—Urticaria—Etoposide—testicular cancer	0.00022	0.00106	CcSEcCtD
Fluvastatin—Rhinitis—Epirubicin—testicular cancer	0.000219	0.00106	CcSEcCtD
Fluvastatin—Abdominal pain—Etoposide—testicular cancer	0.000219	0.00105	CcSEcCtD
Fluvastatin—Body temperature increased—Etoposide—testicular cancer	0.000219	0.00105	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—testicular cancer	0.000219	0.00105	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—testicular cancer	0.000219	0.00105	CcSEcCtD
Fluvastatin—Hepatitis—Epirubicin—testicular cancer	0.000219	0.00105	CcSEcCtD
Fluvastatin—Hypoaesthesia—Epirubicin—testicular cancer	0.000218	0.00105	CcSEcCtD
Fluvastatin—Asthenia—Cisplatin—testicular cancer	0.000217	0.00105	CcSEcCtD
Fluvastatin—Pharyngitis—Epirubicin—testicular cancer	0.000217	0.00104	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—testicular cancer	0.000217	0.00104	CcSEcCtD
Fluvastatin—Sweating—Doxorubicin—testicular cancer	0.000216	0.00104	CcSEcCtD
Fluvastatin—Oedema peripheral—Epirubicin—testicular cancer	0.000216	0.00104	CcSEcCtD
Fluvastatin—Connective tissue disorder—Epirubicin—testicular cancer	0.000215	0.00103	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000213	0.00103	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—testicular cancer	0.000212	0.00102	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—testicular cancer	0.000212	0.00102	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—testicular cancer	0.000211	0.00102	CcSEcCtD
Fluvastatin—Visual impairment—Epirubicin—testicular cancer	0.000211	0.00101	CcSEcCtD
Fluvastatin—Chills—Methotrexate—testicular cancer	0.00021	0.00101	CcSEcCtD
Fluvastatin—Nausea—Ifosfamide—testicular cancer	0.000209	0.001	CcSEcCtD
Fluvastatin—Diarrhoea—Cisplatin—testicular cancer	0.000207	0.000997	CcSEcCtD
Fluvastatin—Erythema multiforme—Epirubicin—testicular cancer	0.000207	0.000995	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—testicular cancer	0.000207	0.000994	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—testicular cancer	0.000205	0.000986	CcSEcCtD
Fluvastatin—Hypersensitivity—Etoposide—testicular cancer	0.000204	0.000983	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—testicular cancer	0.000204	0.000979	CcSEcCtD
Fluvastatin—Flushing—Epirubicin—testicular cancer	0.000203	0.000977	CcSEcCtD
Fluvastatin—Cardiac disorder—Epirubicin—testicular cancer	0.000203	0.000977	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—testicular cancer	0.000203	0.000977	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—testicular cancer	0.000203	0.000974	CcSEcCtD
Fluvastatin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000202	0.000969	CcSEcCtD
Fluvastatin—Pharyngitis—Doxorubicin—testicular cancer	0.000201	0.000967	CcSEcCtD
Fluvastatin—Oedema peripheral—Doxorubicin—testicular cancer	0.0002	0.00096	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—testicular cancer	0.000199	0.000959	CcSEcCtD
Fluvastatin—Asthenia—Etoposide—testicular cancer	0.000199	0.000957	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000199	0.000957	CcSEcCtD
Fluvastatin—Angiopathy—Epirubicin—testicular cancer	0.000199	0.000955	CcSEcCtD
Fluvastatin—Immune system disorder—Epirubicin—testicular cancer	0.000198	0.000951	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—testicular cancer	0.000197	0.000947	CcSEcCtD
Fluvastatin—Chills—Epirubicin—testicular cancer	0.000196	0.000945	CcSEcCtD
Fluvastatin—Pruritus—Etoposide—testicular cancer	0.000196	0.000944	CcSEcCtD
Fluvastatin—Arrhythmia—Epirubicin—testicular cancer	0.000196	0.000941	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—testicular cancer	0.000195	0.000939	CcSEcCtD
Fluvastatin—Alopecia—Epirubicin—testicular cancer	0.000193	0.00093	CcSEcCtD
Fluvastatin—Vomiting—Cisplatin—testicular cancer	0.000193	0.000926	CcSEcCtD
Fluvastatin—Mental disorder—Epirubicin—testicular cancer	0.000192	0.000922	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—testicular cancer	0.000192	0.000921	CcSEcCtD
Fluvastatin—Rash—Cisplatin—testicular cancer	0.000191	0.000918	CcSEcCtD
Fluvastatin—Dermatitis—Cisplatin—testicular cancer	0.000191	0.000918	CcSEcCtD
Fluvastatin—Erythema—Epirubicin—testicular cancer	0.000191	0.000917	CcSEcCtD
Fluvastatin—Diarrhoea—Etoposide—testicular cancer	0.00019	0.000913	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—testicular cancer	0.000189	0.000909	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—testicular cancer	0.000188	0.000904	CcSEcCtD
Fluvastatin—Cardiac disorder—Doxorubicin—testicular cancer	0.000188	0.000904	CcSEcCtD
Fluvastatin—Flatulence—Epirubicin—testicular cancer	0.000188	0.000903	CcSEcCtD
Fluvastatin—Dysgeusia—Epirubicin—testicular cancer	0.000187	0.000898	CcSEcCtD
Fluvastatin—Back pain—Epirubicin—testicular cancer	0.000184	0.000887	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—testicular cancer	0.000184	0.000884	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—testicular cancer	0.000184	0.000883	CcSEcCtD
Fluvastatin—Dizziness—Etoposide—testicular cancer	0.000183	0.000882	CcSEcCtD
Fluvastatin—Muscle spasms—Epirubicin—testicular cancer	0.000183	0.000881	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—testicular cancer	0.000183	0.00088	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—testicular cancer	0.000183	0.00088	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—testicular cancer	0.000182	0.000877	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—testicular cancer	0.000182	0.000874	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—testicular cancer	0.000181	0.00087	CcSEcCtD
Fluvastatin—Nausea—Cisplatin—testicular cancer	0.00018	0.000865	CcSEcCtD
Fluvastatin—Alopecia—Doxorubicin—testicular cancer	0.000179	0.000861	CcSEcCtD
Fluvastatin—Cough—Methotrexate—testicular cancer	0.000178	0.000855	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—testicular cancer	0.000177	0.000853	CcSEcCtD
Fluvastatin—Ill-defined disorder—Epirubicin—testicular cancer	0.000177	0.00085	CcSEcCtD
Fluvastatin—Vomiting—Etoposide—testicular cancer	0.000176	0.000848	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—testicular cancer	0.000176	0.000848	CcSEcCtD
Fluvastatin—Rash—Etoposide—testicular cancer	0.000175	0.000841	CcSEcCtD
Fluvastatin—Dermatitis—Etoposide—testicular cancer	0.000175	0.000841	CcSEcCtD
Fluvastatin—Headache—Etoposide—testicular cancer	0.000174	0.000836	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—testicular cancer	0.000174	0.000836	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—testicular cancer	0.000173	0.000834	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—testicular cancer	0.000173	0.000834	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—testicular cancer	0.000173	0.000834	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—testicular cancer	0.000173	0.00083	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000172	0.000828	CcSEcCtD
Fluvastatin—Malaise—Epirubicin—testicular cancer	0.000172	0.000827	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—testicular cancer	0.000171	0.000824	CcSEcCtD
Fluvastatin—Vertigo—Epirubicin—testicular cancer	0.000171	0.000823	CcSEcCtD
Fluvastatin—Syncope—Epirubicin—testicular cancer	0.000171	0.000822	CcSEcCtD
Fluvastatin—Leukopenia—Epirubicin—testicular cancer	0.000171	0.00082	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—testicular cancer	0.000171	0.00082	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—testicular cancer	0.00017	0.000815	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—testicular cancer	0.000168	0.000806	CcSEcCtD
Fluvastatin—Loss of consciousness—Epirubicin—testicular cancer	0.000167	0.000806	CcSEcCtD
Fluvastatin—Cough—Epirubicin—testicular cancer	0.000166	0.0008	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—testicular cancer	0.000166	0.000799	CcSEcCtD
Fluvastatin—Infection—Methotrexate—testicular cancer	0.000165	0.000794	CcSEcCtD
Fluvastatin—Nausea—Etoposide—testicular cancer	0.000165	0.000793	CcSEcCtD
Fluvastatin—Hypertension—Epirubicin—testicular cancer	0.000165	0.000791	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000164	0.000787	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—testicular cancer	0.000163	0.000784	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—testicular cancer	0.000163	0.000783	CcSEcCtD
Fluvastatin—Chest pain—Epirubicin—testicular cancer	0.000162	0.00078	CcSEcCtD
Fluvastatin—Arthralgia—Epirubicin—testicular cancer	0.000162	0.00078	CcSEcCtD
Fluvastatin—Myalgia—Epirubicin—testicular cancer	0.000162	0.00078	CcSEcCtD
Fluvastatin—Anxiety—Epirubicin—testicular cancer	0.000162	0.000778	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—testicular cancer	0.000161	0.000776	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000161	0.000775	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—testicular cancer	0.000161	0.000773	CcSEcCtD
Fluvastatin—Discomfort—Epirubicin—testicular cancer	0.00016	0.000771	CcSEcCtD
Fluvastatin—Malaise—Doxorubicin—testicular cancer	0.000159	0.000765	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—testicular cancer	0.000158	0.000762	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—testicular cancer	0.000158	0.000762	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—testicular cancer	0.000158	0.00076	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—testicular cancer	0.000158	0.000759	CcSEcCtD
Fluvastatin—Confusional state—Epirubicin—testicular cancer	0.000157	0.000754	CcSEcCtD
Fluvastatin—Anaphylactic shock—Epirubicin—testicular cancer	0.000156	0.000748	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—testicular cancer	0.000155	0.000745	CcSEcCtD
Fluvastatin—Infection—Epirubicin—testicular cancer	0.000155	0.000743	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—testicular cancer	0.000154	0.00074	CcSEcCtD
Fluvastatin—Shock—Epirubicin—testicular cancer	0.000153	0.000736	CcSEcCtD
Fluvastatin—Nervous system disorder—Epirubicin—testicular cancer	0.000153	0.000734	CcSEcCtD
Fluvastatin—Thrombocytopenia—Epirubicin—testicular cancer	0.000152	0.000732	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—testicular cancer	0.000152	0.000732	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000151	0.000728	CcSEcCtD
Fluvastatin—Skin disorder—Epirubicin—testicular cancer	0.000151	0.000727	CcSEcCtD
Fluvastatin—Hyperhidrosis—Epirubicin—testicular cancer	0.00015	0.000723	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—testicular cancer	0.00015	0.000723	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—testicular cancer	0.00015	0.000722	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—testicular cancer	0.00015	0.000722	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—testicular cancer	0.00015	0.000722	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—testicular cancer	0.00015	0.000719	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—testicular cancer	0.000149	0.000718	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000149	0.000717	CcSEcCtD
Fluvastatin—Discomfort—Doxorubicin—testicular cancer	0.000148	0.000713	CcSEcCtD
Fluvastatin—Anorexia—Epirubicin—testicular cancer	0.000148	0.000713	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—testicular cancer	0.000148	0.000713	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—testicular cancer	0.000146	0.000704	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—testicular cancer	0.000145	0.000698	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—testicular cancer	0.000144	0.000695	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000144	0.000692	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000143	0.00069	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—testicular cancer	0.000143	0.000689	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—testicular cancer	0.000143	0.000688	CcSEcCtD
Fluvastatin—Pain—Methotrexate—testicular cancer	0.000142	0.000684	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000142	0.000681	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—testicular cancer	0.000142	0.000681	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—testicular cancer	0.000141	0.000679	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000141	0.000678	CcSEcCtD
Fluvastatin—Insomnia—Epirubicin—testicular cancer	0.000141	0.000677	CcSEcCtD
Fluvastatin—Skin disorder—Doxorubicin—testicular cancer	0.00014	0.000672	CcSEcCtD
Fluvastatin—Paraesthesia—Epirubicin—testicular cancer	0.00014	0.000672	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000139	0.000669	CcSEcCtD
Fluvastatin—Dyspnoea—Epirubicin—testicular cancer	0.000139	0.000667	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—testicular cancer	0.000137	0.00066	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—testicular cancer	0.000137	0.000659	CcSEcCtD
Fluvastatin—Dyspepsia—Epirubicin—testicular cancer	0.000137	0.000658	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000136	0.000654	CcSEcCtD
Fluvastatin—Decreased appetite—Epirubicin—testicular cancer	0.000135	0.00065	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000134	0.000646	CcSEcCtD
Fluvastatin—Fatigue—Epirubicin—testicular cancer	0.000134	0.000645	CcSEcCtD
Fluvastatin—Pain—Epirubicin—testicular cancer	0.000133	0.00064	CcSEcCtD
Fluvastatin—Constipation—Epirubicin—testicular cancer	0.000133	0.00064	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—testicular cancer	0.000132	0.000635	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—testicular cancer	0.000131	0.000632	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—testicular cancer	0.000131	0.000632	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000131	0.000631	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—testicular cancer	0.00013	0.000626	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—testicular cancer	0.000129	0.000621	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—testicular cancer	0.000128	0.000617	CcSEcCtD
Fluvastatin—Feeling abnormal—Epirubicin—testicular cancer	0.000128	0.000616	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000127	0.000612	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—testicular cancer	0.000127	0.000609	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—testicular cancer	0.000125	0.000602	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000124	0.000598	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—testicular cancer	0.000124	0.000597	CcSEcCtD
Fluvastatin—Urticaria—Epirubicin—testicular cancer	0.000124	0.000594	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—testicular cancer	0.000123	0.000592	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—testicular cancer	0.000123	0.000592	CcSEcCtD
Fluvastatin—Body temperature increased—Epirubicin—testicular cancer	0.000123	0.000591	CcSEcCtD
Fluvastatin—Abdominal pain—Epirubicin—testicular cancer	0.000123	0.000591	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—testicular cancer	0.000122	0.000589	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—testicular cancer	0.000119	0.000573	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—testicular cancer	0.000119	0.00057	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000118	0.000566	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—testicular cancer	0.000118	0.000565	CcSEcCtD
Fluvastatin—Hypersensitivity—Epirubicin—testicular cancer	0.000115	0.000551	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—testicular cancer	0.000114	0.00055	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—testicular cancer	0.000114	0.000547	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—testicular cancer	0.000114	0.000547	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—testicular cancer	0.000114	0.000547	CcSEcCtD
Fluvastatin—Asthenia—Epirubicin—testicular cancer	0.000112	0.000537	CcSEcCtD
Fluvastatin—Pruritus—Epirubicin—testicular cancer	0.00011	0.000529	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—testicular cancer	0.00011	0.000529	CcSEcCtD
Fluvastatin—Diarrhoea—Epirubicin—testicular cancer	0.000106	0.000512	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—testicular cancer	0.000106	0.00051	CcSEcCtD
Fluvastatin—Vomiting—Methotrexate—testicular cancer	0.000106	0.000508	CcSEcCtD
Fluvastatin—Rash—Methotrexate—testicular cancer	0.000105	0.000504	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—testicular cancer	0.000105	0.000503	CcSEcCtD
Fluvastatin—Headache—Methotrexate—testicular cancer	0.000104	0.000501	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—testicular cancer	0.000103	0.000497	CcSEcCtD
Fluvastatin—Dizziness—Epirubicin—testicular cancer	0.000103	0.000495	CcSEcCtD
Fluvastatin—Pruritus—Doxorubicin—testicular cancer	0.000102	0.00049	CcSEcCtD
Fluvastatin—Vomiting—Epirubicin—testicular cancer	9.89e-05	0.000476	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—testicular cancer	9.87e-05	0.000475	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—testicular cancer	9.85e-05	0.000474	CcSEcCtD
Fluvastatin—Rash—Epirubicin—testicular cancer	9.81e-05	0.000472	CcSEcCtD
Fluvastatin—Dermatitis—Epirubicin—testicular cancer	9.8e-05	0.000471	CcSEcCtD
Fluvastatin—Headache—Epirubicin—testicular cancer	9.74e-05	0.000469	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—testicular cancer	9.52e-05	0.000458	CcSEcCtD
Fluvastatin—Nausea—Epirubicin—testicular cancer	9.24e-05	0.000444	CcSEcCtD
Fluvastatin—Vomiting—Doxorubicin—testicular cancer	9.15e-05	0.00044	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—testicular cancer	9.07e-05	0.000436	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—testicular cancer	9.07e-05	0.000436	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—testicular cancer	9.02e-05	0.000434	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—testicular cancer	8.55e-05	0.000411	CcSEcCtD
